# 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension

> **NCT00809926** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 451 (actual)

## Conditions studied

- Stage 2 Hypertension

## Interventions

- **DRUG:** Valsartan/aliskiren
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT00809926
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 451 (ACTUAL)
- **Last updated:** 2011-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809926, "8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00809926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*